Lakeshore Hospital and Research Centre Limited
1 MAbout Lakeshore Hospital and Research Centre Limited
A Comprehensive Overview of Price & Journey
Understanding Lakeshore Hospital and Research Centre Limited Inception and Growth
The latest available indicative price of Lakeshore Hospital and Research Centre Limited is approximately ₹89.10 per share as of 4 November 2026, according to Growfast Direct.
However, different platforms are displaying different prices, so the actual transaction price may vary.
1. Latest Unlisted Share Price
Platform
Indicative price
Price date
Growfast Direct
₹89.10
4 November 2026
Moneycontrol
₹94.63
Latest displayed quote
Planify
₹92.70
15 September 2026
UnlistedZone
₹98
28 September 2026
BuyUnlistedShares
₹98
13 September 2026
Sources:
Growfast Direct+4
Important: These are indicative unlisted-market quotations, not confirmed stock exchange prices. Confirm the latest buy price, sell price and available quantity with a dealer before making a transaction.
2. Company Details
Particulars
Details
Company Name
Lakeshore Hospital and Research Centre Limited
ISIN
INE01TI01010
CIN
U85110KL1996PLC010260
Face Value
₹10
Total Equity Shares
10 Crore
Sector
Healthcare
Registered Office
Kochi, Kerala
Official Website
Source:
VPS Lakeshore Hospital+1
3. Business Overview
Lakeshore Hospital and Research Centre Limited operates VPS Lakeshore Hospital, a multi-speciality healthcare institution located in Nettoor, Kochi, Kerala.
The hospital provides healthcare services across various medical specialities, including:
-
Cardiology
-
Neurology
-
Oncology
-
Orthopaedics
-
General Medicine
-
Gastroenterology
-
Surgery
-
Diagnostic and Imaging Services
4. Financial Performance
According to the company's published financial information, its consolidated financial performance was as follows:
Financial Year
Revenue from Operations
Net Profit
FY 2022–23
₹419.18 Cr
₹57.52 Cr
FY 2023–24
₹396.22 Cr
₹43.87 Cr
FY 2024–25
₹407.52 Cr
₹39.12 Cr
FY 2025–26
₹452.74 Cr
₹53.07 Cr
Source: Published company financial statements compiled by Growfast Direct. Figures are in crore rupees.
Growfast Direct
The company reported revenue growth of approximately 11% and net profit growth of approximately 36% in FY 2025–26 compared with FY 2024–25.
SHOW MORE...
The latest available indicative price of Lakeshore Hospital and Research Centre Limited is approximately ₹89.10 per share as of 4 November 2026, according to Growfast Direct.
However, different platforms are displaying different prices, so the actual transaction price may vary.
1. Latest Unlisted Share Price
|
Platform |
Indicative price |
Price date |
|---|---|---|
|
Growfast Direct |
₹89.10 |
4 November 2026 |
|
Moneycontrol |
₹94.63 |
Latest displayed quote |
|
Planify |
₹92.70 |
15 September 2026 |
|
UnlistedZone |
₹98 |
28 September 2026 |
|
BuyUnlistedShares |
₹98 |
13 September 2026 |
Sources:
Growfast Direct+4
Important: These are indicative unlisted-market quotations, not confirmed stock exchange prices. Confirm the latest buy price, sell price and available quantity with a dealer before making a transaction.
2. Company Details
|
Particulars |
Details |
|---|---|
|
Company Name |
Lakeshore Hospital and Research Centre Limited |
|
ISIN |
INE01TI01010 |
|
CIN |
U85110KL1996PLC010260 |
|
Face Value |
₹10 |
|
Total Equity Shares |
10 Crore |
|
Sector |
Healthcare |
|
Registered Office |
Kochi, Kerala |
|
Official Website |
Source:
VPS Lakeshore Hospital+1
3. Business Overview
Lakeshore Hospital and Research Centre Limited operates VPS Lakeshore Hospital, a multi-speciality healthcare institution located in Nettoor, Kochi, Kerala.
The hospital provides healthcare services across various medical specialities, including:
-
Cardiology
-
Neurology
-
Oncology
-
Orthopaedics
-
General Medicine
-
Gastroenterology
-
Surgery
-
Diagnostic and Imaging Services
4. Financial Performance
According to the company's published financial information, its consolidated financial performance was as follows:
|
Financial Year |
Revenue from Operations |
Net Profit |
|---|---|---|
|
FY 2022–23 |
₹419.18 Cr |
₹57.52 Cr |
|
FY 2023–24 |
₹396.22 Cr |
₹43.87 Cr |
|
FY 2024–25 |
₹407.52 Cr |
₹39.12 Cr |
|
FY 2025–26 |
₹452.74 Cr |
₹53.07 Cr |
Source: Published company financial statements compiled by Growfast Direct. Figures are in crore rupees.
Growfast Direct
The company reported revenue growth of approximately 11% and net profit growth of approximately 36% in FY 2025–26 compared with FY 2024–25.
Fundamentals
Financials
All values are INR Cr except per share value
| P&L Statement | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 358.59 | 419.18 | 396.22 |
| Other Income | 3.07 | 5.36 | 6.67 |
| COGS | 102.51 | 111.70 | 111.32 |
| Gross Profit | 259.15 | 312.84 | 291.57 |
| Total Expense | 174.33 | 205.62 | 211.94 |
| D&A | 21.46 | 22.69 | 23.70 |
| EBIT | 63.35 | 84.52 | 55.93 |
| Interest Expense | 2.57 | 2.11 | 0.93 |
| PBT | 60.78 | 82.41 | 55.00 |
| TAX | 17.90 | 24.90 | 11.13 |
| PAT | 42.88 | 57.52 | 43.87 |
| Diluted EPS | 4.29 | 5.75 | 4.39 |
| Basic EPS | 4.29 | 5.75 | 4.39 |
| Total income | 361.66 | 424.54 | 402.89 |
ASSETS
| CURRENT ASSETS | 2022 | 2023 | 2024 |
|---|---|---|---|
| Cash and Cash Equivalents | 11.62 | 36.63 | 9.93 |
| Trade Payables | 20.13 | 19.99 | 26.87 |
| Inventory | 11.06 | 12.72 | 10.71 |
| Other Current Assets | 47.66 | 73.57 | 76.10 |
| Total Current Assets | 90.47 | 142.91 | 123.61 |
| NON CURRENT ASSETS | 2022 | 2023 | 2024 |
|---|---|---|---|
| Plant Property and Equipment | 345.46 | 337.55 | 349.52 |
| Other Non Current Assets | 28.01 | 19.79 | 34.53 |
| Total Non Current Assets | 373.47 | 357.34 | 384.05 |
| Total Assets | 463.94 | 500.25 | 507.66 |
|---|
| CURRENT LIABILITES | 2022 | 2023 | 2024 |
|---|---|---|---|
| TRADW Payable | 33.20 | 35.39 | 32.79 |
| Other Current Liab | 43.15 | 45.80 | 35.84 |
| NON CURRENTLIABILITIES | 2022 | 2023 | 2024 |
|---|---|---|---|
| Long Term Debt | 13.01 | 7.24 | - |
| Deffered Tax Liab | 16.20 | 19.81 | 17.37 |
| Other Non Current Liab | 27.18 | 18.56 | 21.46 |
LIABILITIES
| EQUITY | 2022 | 2023 | 2024 |
|---|---|---|---|
| Share Capital | 100.00 | 100.00 | 100.00 |
| Other Equity | 231.21 | 273.45 | 300.22 |
| Total Equity | 331.21 | 373.45 | 400.22 |
| Total Liabilities & Equity | 331.21 | 373.45 | 400.22 |
|---|
| CASH FLOW STAT | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Cash Flow from operating | - | 31.19 | 54.97 | 44.12 |
| Cash Flow from financing | - | -26.39 | -23.31 | -31.52 |
| Cash Flow from investing | - | -24.04 | -6.65 | -39.30 |
| Net cash flow | 0.00 | -19.24 | 25.01 | -26.70 |
Revenue Growth
PAT Growth %
EPS Growth %
TOTAL ASSETS Growth %
QUICK RATIO Growth %
LONG TERM DEBT TO EQUITY RATIO Growth %
Shareholding Pattern
2026
| Name | Designation | Share % |
|---|---|---|
| Dr. Shamsheer Vayalil Parambath | NA | 42.62% |
| Mr. Yusuff Ali M A | NA | 18.80% |
| Others | NA | 38.58% |
Events
| Name | Date | Details |
|---|---|---|
| No events available. | ||
Frequently Asked Questions
- The lockin period is of 6 months for pre-ipo investors i.e. they cannot sell their shares for 6 months after they get listed. However, they can definitely sell the shares in pre-ipo market before they get listed.
- With BharatInvest, you can now invest in unlisted/pre-ipo shares with as low as 25-50k depending upon the share.
- 1. You can download the NSDL or CDSL application and login into the account and check whether the shares have been credited or not.
- 2. Credit of Unlisted Shares/Pre-IPO shares can be checked in brokers application as well but it takes T+2 days to show the shares.
- The value of share in unlisted space is determined in the same way as it is done in listed market. Demand and supply decide the price of any share. If the demand more than the supply, then the prices of the share increases and vice versa.
- When a new shares is introduces in the unlisted space, the value of the company is decided upon the last funding raised by company. If the company hasn’t raised any funding in the past, then the valuation is decided upon the fundamentals of the company.
- A Public Unlisted Shares Is Not Listed on Stock Exchange, Where as a Listed Public Company Is Listed On Stock Exchange Such As BSE Or NSE For Trading Of Shares.
- If you sell your shares within 2 years, then you will have to pay Short-term Capital gain on unli sted shares. Short-Term Capital Gain is added in your Income. So, as per individual tax slab you need to pay capital gain tax.
- If you sell your shares after 2 years, then you will have to pay Long-term Capital gain on unlisted shares LTCG is 12.5% without indexation benefits.
- After listing of shares, the unlisted shares which you have bought through unlisted market, will be taxed at listed rates, if sold through exchange. So, taxes of listed market will be applicable. And, to calculate holding time, for determining LTCG or STCG, the purchase date of unlisted shares will be applicable.
- Absoluetly NOT! Grey market is all about speculation relation to open price, subscription rate etc. And does not include physical delivery of shares. Whereas in pre ipo market you get to invest in shares much before the ipo too and it involves physical delivery of shares. It is compeletly legal and does not include any such speculation.
- Existing stakeholders, promoters or employees who have equity shares of an unlisted company and early investors who wish to get value of their investment.
- Yes, investing in unlisted shares is undoubtedly legal in India. The trading takes place in the over-the-counter market.